The Importance of the RSV Vaccine During Pregnancy

Protecting Your Newborn: The Importance of the RSV Vaccine During Pregnancy

This vaccine is an important preventive measure recommended by our physicians for all pregnant patients who expect to deliver between September and January. In this blog post, we’ll explore what RSV is, the significance of the vaccine, and why it’s essential for expecting mothers.

What is RSV?

Respiratory syncytial virus (RSV) is a highly contagious respiratory virus that affects the lungs and breathing tubes. While it often manifests as a common cold in healthy adults, it can cause severe illness in babies and young children. RSV is the leading cause of hospitalization among infants in the United States. Virtually all children will have contracted RSV by the time they are two years old. Annually, an estimated 58,000 to 80,000 children under five are hospitalized due to RSV infection. The risk is highest among premature infants and those under 12 months old.

Understanding the RSV Vaccine

Abrysvo is the only RSV vaccine approved for use during pregnancy. Our physicians recommend administering it between 32 and 36 weeks of pregnancy. Since RSV is a seasonal virus, similar to the flu, the timing of the vaccine is crucial. Pregnant women who are expected to give birth between September and January should receive the vaccine during this window to ensure optimal protection for their newborns.

Why Get the RSV Vaccine During Pregnancy?

Receiving the RSV vaccine during pregnancy offers significant benefits:

1. Passive Immunity for Your Baby: Similar to the flu, Tdap, and COVID-19 vaccines, when Abrysvo is administered in the third trimester, it helps your body develop antibodies. These antibodies are then passed to your baby through the placenta, providing protection from birth until six months old.
2. Effectiveness: Studies have shown that Abrysvo can reduce the risk of severe RSV illness in infants by about 70%.
3. Safety: Abrysvo has been rigorously studied in thousands of pregnancies and has demonstrated no safety concerns when administered during the third trimester. Common side effects are mild and may include pain at the injection site, headache, muscle pain, and nausea.

When Will It Be Available?

We are currently finalizing the availability of the vaccine and expect it to be ready by early Fall 2024.  Please stay tuned for the exact date.  We will keep you updated with all the necessary information to help you plan your visit.

Additional Information

• RSV Injection Post-Birth: If you receive the Abrysvo vaccine at least 14 days before delivery, your baby will not require the RSV injection (Beyfortus/nirsevimab) after birth. Ensure your pediatrician is informed about the vaccination.
• Combination with Other Vaccines: Abrysvo can be administered alongside other vaccines recommended during pregnancy without any issues.
• Endorsements: The recommendation for the RSV vaccine comes from reputable organizations including the American College of Obstetricians and Gynecologists (ACOG), the Centers for Disease Control and Prevention (CDC), and the Advisory Committee on Immunization Practices (ACIP).

Conclusion

At Women’s Health Associates, your health and the well-being of your baby are our top priorities. The introduction of the RSV vaccine (Abrysvo) in our office represents a significant advancement in protecting newborns from severe respiratory illnesses. Our doctors highly recommend that pregnant patients receive this vaccine if they are delivering during the appropriate time. We are dedicated to keeping you informed and ensuring a smooth experience as we roll out this essential service. 

If you have any questions or need further information, please do not hesitate to contact our office. Stay tuned for updates and thank you for entrusting us with your care. Our team is here to support every aspect of your pregnancy journey.  

This article is for informational purposes only and does not constitute medical advice. Consult with a healthcare professional for personalized advice.